Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 12
1948 23
1949 30
1950 47
1951 49
1952 66
1953 59
1954 70
1955 69
1956 60
1957 98
1958 54
1959 61
1960 52
1961 60
1962 42
1963 59
1964 48
1965 42
1966 65
1967 63
1968 39
1969 52
1970 70
1971 50
1972 105
1973 59
1974 39
1975 42
1976 38
1977 58
1978 71
1979 105
1980 92
1981 87
1982 119
1983 102
1984 94
1985 138
1986 93
1987 155
1988 117
1989 175
1990 222
1991 196
1992 128
1993 117
1994 109
1995 122
1996 110
1997 193
1998 236
1999 330
2000 402
2001 354
2002 384
2003 346
2004 380
2005 477
2006 476
2007 399
2008 453
2009 417
2010 450
2011 449
2012 453
2013 444
2014 433
2015 427
2016 424
2017 497
2018 608
2019 733
2020 527
2021 491
2022 433
2023 535
2024 330

Text availability

Article attribute

Article type

Publication date

Search Results

14,833 results

Results by year

Filters applied: . Clear all
Page 1
Talquetamab in multiple myeloma.
Liu L, Krishnan A. Liu L, et al. Haematologica. 2024 Mar 1;109(3):718-724. doi: 10.3324/haematol.2023.283931. Haematologica. 2024. PMID: 37855056 Free PMC article.
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study.
Duell J, Abrisqueta P, Andre M, Gaidano G, Gonzales-Barca E, Jurczak W, Kalakonda N, Liberati AM, Maddocks KJ, Menne T, Nagy Z, Tournilhac O, Kuffer C, Bakuli A, Amin A, Gurbanov K, Salles G. Duell J, et al. Haematologica. 2024 Feb 1;109(2):553-566. doi: 10.3324/haematol.2023.283480. Haematologica. 2024. PMID: 37646664 Free PMC article. Clinical Trial.
Emicizumab: the hemophilia A game changer.
Alcedo Andrade PE, Mannucci PM, Kessler CM. Alcedo Andrade PE, et al. Haematologica. 2023 Nov 2. doi: 10.3324/haematol.2022.282099. Online ahead of print. Haematologica. 2023. PMID: 37916312 Free article.
How we manage a high D-dimer.
Franchini M, Focosi D, Pezzo MP, Mannucci PM. Franchini M, et al. Haematologica. 2024 Apr 1;109(4):1035-1045. doi: 10.3324/haematol.2023.283966. Haematologica. 2024. PMID: 37881856 Free PMC article. Review.
ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms.
Riabov V, Xu Q, Schmitt N, Streuer A, Ge G, Bolanos L, Wunderlich M, Jann JC, Wein A, Altrock E, Demmerle M, Mukherjee S, Ali AM, Rapp F, Nowak V, Weimer N, Obländer J, Palme I, Göl M, Jawhar A, Darwich A, Wuchter P, Weiss C, Raza A, Foulks JM, Starczynowski DT, Yang FC, Metzgeroth G, Steiner L, Jawhar M, Hofmann WK, Nowak D. Riabov V, et al. Haematologica. 2023 Nov 2. doi: 10.3324/haematol.2023.282921. Online ahead of print. Haematologica. 2023. PMID: 37916386 Free article.
Granulocyte transfusions in severe aplastic anemia.
Rajput RV, Shah V, Shalhoub RN, West-Mitchell K, Cha NR, Conry-Cantilena C, Leitman SF, Young DJ, Wells B, Aue G, Dunbar CE, Patel BA, Childs RW, Young NS, Wu CO, Groarke EM, Kalsi SS. Rajput RV, et al. Haematologica. 2023 Dec 7. doi: 10.3324/haematol.2023.283826. Online ahead of print. Haematologica. 2023. PMID: 38058170 Free article.
14,833 results
You have reached the last available page of results. Please see the User Guide for more information.